Healthway Medical Corporation Limited: Do Stock Valuation Metrics Render Financial Analysis Redundant?
受取状況を読み込めませんでした
Alan Wong, an intern at Gem Asset Management, was pleasantly surprised when, as per his supervisor's instructions, reviewed the stock multiples (P/E, P/Sales, P/Book Value, and EV/EBITDA) of healthcare stocks listed on the Singapore Exchange (SGX). He recalled from his Equity Analysis 101 class at business school that the stock valuation metrics of companies in the same industry tended to trade within a narrow range. But certain stock valuation metrics of Healthway Medical Corporation appeared attractive in relation to SGX-listed peers. Alan performs the Du Pont analysis and financial statement analysis to ascertain if the Healthway stock was indeed attractive against the backdrop of its performance. Did the conclusions of his analysis support his initial impression?
【書誌情報】
ページ数：27ページ
サイズ：A4
商品番号：HBSP-NTU129
発行日：2017/7/27
登録日：2017/8/17
